Cascade Investment Advisors, Inc. Novartis Ag Transaction History

Cascade Investment Advisors, Inc.

  • $156 Million
  • Q3 2024

A detailed history of Cascade Investment Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cascade Investment Advisors, Inc. holds 22,310 shares of NVS stock, worth $2.42 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares
22,310
Previous 22,610 1.33%
Holding current value
$2.42 Million
Previous $2.41 Million 6.61%
% of portfolio
1.65%
Previous 1.64%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024
SELL
$106.13 - $120.89 $31,839 - $36,267
-300 Reduced 1.33%
22,310 $2.57 Million
Q2 2024

Jul 08, 2024
BUY
$92.57 - $107.37 $1,851 - $2,147
20 Added 0.09%
22,610 $2.41 Million
Q1 2024

Apr 24, 2024
BUY
$95.27 - $108.47 $32,391 - $36,879
340 Added 1.53%
22,590 $2.19 Million
Q4 2023

Jan 11, 2024
SELL
$92.27 - $101.54 $2,768 - $3,046
-30 Reduced 0.13%
22,250 $2.25 Million
Q3 2023

Oct 30, 2023
SELL
$94.73 - $105.13 $18,188 - $20,184
-192 Reduced 0.85%
22,280 $2.27 Million
Q2 2023

Jul 21, 2023
SELL
$92.52 - $104.91 $62,728 - $71,128
-678 Reduced 2.93%
22,472 $2.27 Million
Q1 2023

May 10, 2023
BUY
$80.03 - $92.81 $2,000 - $2,320
25 Added 0.11%
23,150 $2.13 Million
Q4 2022

Jan 26, 2023
SELL
$75.55 - $92.52 $5,288 - $6,476
-70 Reduced 0.3%
23,125 $0
Q3 2022

Nov 15, 2022
BUY
$74.61 - $87.26 $20,144 - $23,560
270 Added 1.18%
23,195 $1.88 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $23,511 - $27,375
-292 Reduced 1.26%
22,925 $1.94 Billion
Q1 2022

Apr 11, 2022
SELL
$80.11 - $90.62 $17,864 - $20,208
-223 Reduced 0.95%
23,217 $2.04 Million
Q4 2021

Feb 10, 2022
BUY
$79.7 - $88.13 $77,309 - $85,486
970 Added 4.32%
23,440 $2.05 Million
Q3 2021

Oct 21, 2021
BUY
$81.78 - $95.14 $73,602 - $85,626
900 Added 4.17%
22,470 $1.84 Billion
Q2 2021

Aug 04, 2021
SELL
$85.24 - $94.15 $5,966 - $6,590
-70 Reduced 0.32%
21,570 $1.97 Million
Q1 2021

Apr 23, 2021
BUY
$83.5 - $98.47 $33,400 - $39,388
400 Added 1.88%
21,640 $1.85 Million
Q4 2020

Jan 21, 2021
BUY
$78.07 - $94.43 $26,153 - $31,634
335 Added 1.6%
21,240 $2.01 Billion
Q3 2020

Oct 14, 2020
BUY
$82.14 - $91.0 $6,981 - $7,735
85 Added 0.41%
20,905 $1.82 Billion
Q2 2020

Jul 15, 2020
SELL
$80.93 - $91.1 $4,046 - $4,555
-50 Reduced 0.24%
20,820 $1.82 Billion
Q1 2020

Apr 21, 2020
SELL
$70.67 - $99.01 $31,448 - $44,059
-445 Reduced 2.09%
20,870 $1.72 Billion
Q4 2019

Jan 22, 2020
SELL
$84.35 - $95.37 $96,159 - $108,721
-1,140 Reduced 5.08%
21,315 $2.02 Billion
Q3 2019

Oct 22, 2019
BUY
$85.54 - $94.26 $44,053 - $48,543
515 Added 2.35%
22,455 $1.95 Billion
Q2 2019

Jul 18, 2019
BUY
$75.4 - $92.8 $17,719 - $21,808
235 Added 1.08%
21,940 $2 Billion
Q1 2019

Apr 15, 2019
SELL
$75.32 - $86.15 $22,595 - $25,845
-300 Reduced 1.36%
21,705 $2.09 Billion
Q4 2018

Jan 25, 2019
SELL
$73.66 - $82.02 $10,312 - $11,482
-140 Reduced 0.63%
22,005 $1.89 Billion
Q3 2018

Oct 12, 2018
SELL
$66.94 - $77.43 $21,755 - $25,164
-325 Reduced 1.45%
22,145 $1.91 Billion
Q2 2018

Jul 31, 2018
SELL
$64.91 - $73.36 $245,359 - $277,300
-3,780 Reduced 14.4%
22,470 $1.7 Billion
Q1 2018

Apr 23, 2018
BUY
$70.39 - $84.15 $43,993 - $52,593
625 Added 2.44%
26,250 $2.12 Billion
Q4 2017

Jan 17, 2018
BUY
$72.33 - $77.64 $9,402 - $10,093
130 Added 0.51%
25,625 $2.15 Billion
Q3 2017

Oct 12, 2017
BUY
$74.14 - $77.27 $1.89 Million - $1.97 Million
25,495
25,495 $2.19 Billion

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cascade Investment Advisors, Inc. Portfolio

Follow Cascade Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email